Essential tremor (ET) is the most common movement disorder in the adult population. At present ET treatment shows limited efficacy, particularly in patients with severe and disabling symptoms. This study evaluates the clinical efficacy of mirtazapine in an untreated ET patient population.
Uccellini, D., Grampa, G., La Spina, I., Nasuelli, D., Neromante, I., Politini, L., Reverberi, F., Porazzi, D., Carli, V., Camardese, G., Mirtazapine in the treatment of essential tremor: an open-label, observer-blind study, <<NEUROPSYCHIATRIC DISEASE AND TREATMENT>>, 2006; 2 (1): 95-100 [http://hdl.handle.net/10807/7922]
Autori: | ||
Titolo: | Mirtazapine in the treatment of essential tremor: an open-label, observer-blind study | |
Data di pubblicazione: | 2006 | |
Abstract: | Essential tremor (ET) is the most common movement disorder in the adult population. At present ET treatment shows limited efficacy, particularly in patients with severe and disabling symptoms. This study evaluates the clinical efficacy of mirtazapine in an untreated ET patient population. | |
Lingua: | Inglese | |
Rivista: | ||
Citazione: | Uccellini, D., Grampa, G., La Spina, I., Nasuelli, D., Neromante, I., Politini, L., Reverberi, F., Porazzi, D., Carli, V., Camardese, G., Mirtazapine in the treatment of essential tremor: an open-label, observer-blind study, <<NEUROPSYCHIATRIC DISEASE AND TREATMENT>>, 2006; 2 (1): 95-100 [http://hdl.handle.net/10807/7922] | |
Appare nelle tipologie: | Articolo in rivista, Nota a sentenza |
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.